You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
22 September 2026 - Biotechnology company Genentech, a member of the Roche Group (SIX: RO, ROG) (OTCQX: RHHBY), on Tuesday reported positive topline Phase II results for enicepatide, an investigational once-weekly dual GLP-1/GIP receptor agonist, in ...
22 September 2026 - US pharmaceutical company AbbVie (NYSE:ABBV), and Iambic, a clinical-stage life sciences and technology company developing novel medicines through its AI-driven discovery and development platform, announced on Monday a multi-year ...
22 September 2026 - Denmark-based vaccines company Bavarian Nordic A/S (CPH:BAVA) on Monday published an update on its share buy-back programme launched on 1 September 2026, under which the company will repurchase shares for an amount up to DKK250m i...
22 September 2026 - Grunenthal, a German pharmaceutical company focused on pain management and related diseases, announced on Monday that it has entered into an agreement with German pharmaceutical and life sciences company Bayer AG (ETR:BAYN) (OTC:B...
21 September 2026 - Biopharmaceutical company Insmed Incorporated (Nasdaq: INSM) disclosed on Monday that the US Food and Drug Administration has accepted its supplemental New Drug Application for ARIKAYCE (amikacin liposome inhalation suspension) fo...
21 September 2026 - Biopharmaceutical company Precigen Inc (Nasdaq: PGEN) disclosed on Monday that it has received US Food and Drug Administration platform technology designation for its AdenoVerse immunotherapeutic platform, which underpins its firs...
21 September 2026 - British-Swedish biopharmaceutical company AstraZeneca plc (STO:AZN) (LON:AZN) (NYSE:AZN) and Japanese healthcare company Daiichi Sankyo Co Ltd (TYO:4568) announced on Monday that Enhertu (trastuzumab deruxtecan) has been recommend...